As a traditionally risk-averse nation, India has rarely been at the forefront of innovation. Indian companies have mostly imitated others and became… — Kiran Mazumdar-Shaw Copy Share Image
I am very concerned about the fact that India as a country does not have a national health system, and I am… — Kiran Mazumdar-Shaw Copy Share Image
I hate the title of being called 'the richest woman in India,' but it's the recognition that this was the value that… — Kiran Mazumdar-Shaw Copy Share Image
You have to build a culture of philanthropy. In a country like India, we need to be sensitive and caring about the… — Kiran Mazumdar-Shaw Copy Share Image
Indian business women like Indra Nooyi, Chanda Kochhar, Naina Lal Kidwai, Shikha Sharma, Swati Piramal, Anu Agha, Swati Piramal, Sulajja Firodia Motwani… — Kiran Mazumdar-Shaw Copy Share Image
It was a chance encounter with a biotech entrepreneur from Ireland that got me started as an entrepreneur in India, because I… — Kiran Mazumdar-Shaw Copy Share Image
I want to be remembered as someone who put India on the scientific map of the world in terms of large innovation.… — Kiran Mazumdar-Shaw Copy Share Image
I guess I was very fortunate; I had a very very, lets put it this way, I had very wonderful upbringing and… — Kiran Mazumdar-Shaw Copy Share Image
In Vedic times, we had the great quest for the unknown. We did wonderful things; we celebrate our past vigyaan and our wonderful heritage… — Kiran Mazumdar-Shaw Copy Share Image
People believe that art and science are two distinct realms. It is far from the truth because, if you look at science from a… — Kiran Mazumdar-Shaw Copy Share Image
Unfortunately, our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon… — Kiran Mazumdar-Shaw Copy Share Image
I want to make sure that our bio-similars capture a huge market share and help cancer patients around the world, which we are already… — Kiran Mazumdar-Shaw Copy Share Image
I have successfully challenged the Western world's existing model of pharmaceutical innovation, which leads to the creation of monopolistic markets for novel, life-saving drugs… — Kiran Mazumdar-Shaw Copy Share Image
I faced a number of challenges whilst I built Biocon. Initially, I had credibility challenges where I couldn't get banks to fund me; I… — Kiran Mazumdar-Shaw Copy Share Image
We need to ask ourselves: What use is our scientific endeavor and innovation when they are inaccessible to the people who need them the… — Kiran Mazumdar-Shaw Copy Share Image
As a traditionally risk-averse nation, India has rarely been at the forefront of innovation. Indian companies have mostly imitated others and became very good… — Kiran Mazumdar-Shaw Copy Share Image
Innovation and commerce are as powerful tools for creating social progress as they are for driving technological advancement. — Kiran Mazumdar-Shaw Copy Share Image
